Filter by: patients
Home > Community Treatment Reports and Side Effects > Bevacizumab Treatment Report
What is Bevacizumab?

Bevacizumab is a monoclonal antibody and vascular endothelial growth factor inhibitor used for various types of cancer. Off label it has been used for recurrent ovarian cancer and age-related macular degeneration.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Macular degeneration 4 1 Efficacy_slight
Other 1 1 Efficacy_major
Glioblastoma multiforme 1 0
Ovarian Cancer 1 1 Efficacy_cant_tell
Colon Cancer 1 0

See all 4 patients currently taking Bevacizumab

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 2
Moderate
 1
Mild
 0
None
 0

Commonly reported side effects, conditions, and hospitalizations associated with Bevacizumab

Spasms 1
Hair loss 1
Opening wounds, which temporarily increase depression & anxiety 1
Hospitalization 1

Reported Dosages

  1liter as needed 2 25mg/mL as needed 25 mg every 6 weeks 630 mg every other week
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Bevacizumab (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 4   Other: 67%
Side effects too severe 2   Side effects too severe: 33%
Doctor's advice 1   Doctor's advice: 17%
Course of treatment ended 1   Course of treatment ended: 17%
Not indicated 1   Not indicated: 17%

See all 6 patients who’ve stopped taking Bevacizumab

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Bevacizumab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Bevacizumab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Bevacizumab

Always
 1 33%
Usually
 0 0%
Sometimes
 1 33%
Never
 1 33%

Burden

Difficulty being on treatment

Burden of Bevacizumab

Very
 2 67%
Somewhat
 1 33%
A little
 0 0%
Not at all
 0 0%

Cost

Paid out of pocket

Cost of Bevacizumab

$200+
 1 100%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.